HMOX1 and myocardial infarction: In summary, our results demonstrated that haemin pre‐treatment, via up‐regulation of HO‐1 levels, significantly enhanced BM‐MSC survival under ischaemic conditions by inhibiting mitochondrial fission, thus improving the therapeutic effects for treating MI.